NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
-13.81%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$528M
AUM Growth
+$528M
(+26%)
Cap. Flow
+$180M
Cap. Flow
% of AUM
34.07%
Top 10 Holdings %
Top 10 Hldgs %
50.68%
Holding
87
New
48
Increased
19
Reduced
11
Closed
3
Top Buys
| 1 |
Cannae Holdings
CNNE
|
$27.1M |
| 2 |
IAC Inc
IAC
|
$25.5M |
| 3 |
Ardagh Metal Packaging
AMBP
|
$23M |
| 4 |
ONL
Orion Office REIT
ONL
|
$13.3M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$11.1M |
Top Sells
| 1 |
LYLT
Loyalty Ventures Inc. Common Stock
LYLT
|
$9.48M |
| 2 |
RLJ Lodging Trust $1.95 Series A Cumulative Convertible Preferred Shares
RLJ.PRA
|
$6.6M |
| 3 |
PG&E
PCG
|
$4.59M |
| 4 |
TSVT
2seventy bio
TSVT
|
$3.18M |
| 5 |
Algoma Steel
ASTL
|
$2.45M |
Sector Composition
| 1 | Healthcare | 23.3% |
| 2 | Consumer Discretionary | 16.93% |
| 3 | Financials | 13.63% |
| 4 | Real Estate | 8.52% |
| 5 | Technology | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GeneDx Holdings
WGS
$3.68B
| $1.44M | 0.27% |
1,145,000
+545,000
| +91% | +$687K |
|
52
Invivyd
IVVD
$209M
| $1.32M | 0.25% |
+400,875
| New | +$1.32M |
|
53
Wave Life Sciences
WVE
$1.54B
| $1.31M | 0.25% |
+403,553
| New | +$1.31M |
|
|
DBTX
54
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $1.31M | 0.25% |
+310,000
| New | +$1.31M |
|
55
Black Diamond Therapeutics
BDTX
$160M
| $1.28M | 0.24% |
+520,000
| New | +$1.28M |
|
56
Adverum Biotechnologies
ADVM
$63.2M
| $1.24M | 0.24% |
+1,035,000
| New | +$1.24M |
|
57
Aligos Therapeutics
ALGS
$71M
| $1.16M | 0.22% |
+962,088
| New | +$1.16M |
|
58
Iovance Biotherapeutics
IOVA
$792M
| $1.16M | 0.22% |
+105,000
| New | +$1.16M |
|
59
Alector
ALEC
$255M
| $1.07M | 0.2% |
+105,000
| New | +$1.07M |
|
60
89bio
ETNB
$1.34B
| $998K | 0.19% |
+310,000
| New | +$998K |
|
|
EAR
61
DELISTED
Eargo, Inc. Common Stock
EAR
| $987K | 0.19% |
1,312,066
-637,934
| -33% | -$480K |
|
62
Sensei Biotherapeutics
SNSE
$9.9M
| $942K | 0.18% |
+415,000
| New | +$942K |
|
63
Alpha Metallurgical Resources
AMR
$1.83B
| $816K | 0.15% |
6,319
| – | – |
|
64
TScan Therapeutics
TCRX
$102M
| $782K | 0.15% |
+248,611
| New | +$782K |
|
|
QD
65
Qudian
QD
$769M
| $759K | 0.14% |
+690,290
| New | +$759K |
|
66
Nuvation Bio
NUVB
$1.02B
| $680K | 0.13% |
+210,000
| New | +$680K |
|
67
Oric Pharmaceuticals
ORIC
$1B
| $672K | 0.13% |
+150,000
| New | +$672K |
|
68
Rafael Holdings
RFL
$49.1M
| $561K | 0.11% |
300,000
-98,913
| -25% | -$185K |
|
|
SIOX
69
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $510K | 0.1% |
+1,415,859
| New | +$510K |
|
|
KRON
70
DELISTED
Kronos Bio
KRON
| $461K | 0.09% |
+126,623
| New | +$461K |
|
|
DOMA
71
DELISTED
Doma Holdings, Inc.
DOMA
| $309K | 0.06% |
+300,000
| New | +$309K |
|
|
TLIS
72
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $231K | 0.04% |
+284,726
| New | +$231K |
|
|
AMYT
73
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $207K | 0.04% |
+29,656
| New | +$207K |
|
74
BioAtla
BCAB
$27M
| $186K | 0.04% |
+65,332
| New | +$186K |
|
|
LAXXR
75
DELISTED
8i Acquisition 2 Corp. Rights
LAXXR
| $173K | 0.03% |
+750,000
| New | +$173K |
|